Product Program year 2024 Source: CMS Open Payments

Qalsody

Drug Neurology

NDC 64406-109-01

Open in the dashboard

General payments

$17,203

365 payments

Research payments

$2,742,293

34 payments

Through program year 2024, $17,203 in general payments and $2,742,293 in research payments were reported against Qalsody (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $11,139 340
2024 Research $2,690,848 31
2023 General $6,065 25
2023 Research $51,445 3

Breakdown

Who paid General payments · program years 2023–2024
  1. Biogen, Inc. $17,203 365 payments
Top recipients General payments · program year 2024
  1. Marisa McGhee Neuromuscular Medicine · Winston Salem, NC $227 2% · 5 payments
  2. Natalia Gonzalez Caldito Neurology · Honolulu, HI $220 2% · 3 payments
  3. Michael Cartwright Neurology · Winston Salem, NC $190 2% · 4 payments
  4. James Caress Clinical Neurophysiology · Winston Salem, NC $190 2% · 4 payments
  5. Francis Walker Neurology · Winston Salem, NC $190 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Neurology Psychiatry & Neurology $6,025 55% · 129 practitioners
  2. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $744 7% · 9 practitioners
  3. Physician Assistant $618 6% · 21 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $604 5% · 21 practitioners
  5. Physical Medicine & Rehabilitation $508 5% · 7 practitioners

The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $2,559 23% · 52 recipients
  2. North Carolina $1,619 15% · 19 recipients
  3. Arkansas $752 7% · 24 recipients
  4. Puerto Rico $662 6% · 5 recipients
  5. New Jersey $602 5% · 10 recipients

The top 5 of 34 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

35

Prescriptions dispensed, refills included

Drug cost

$551,231

Paid at the pharmacy, in all

Prescribers

3

With 11 or more claims of it

Medicare Part D drugs matched to QALSODY, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Qalsody Tofersen Same name 3 35 $551,231

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

3 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Hannah MacHemehl Internal Medicine NC 12 $196,695 None on record
Britton Zuccarelli Pediatric Medicine KS 12 $177,683 None on record
Joanna Dearlove Neurology CA 11 $176,854 No profile

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

365 general · 34 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record